Cargando…

Association of Serum Neurofilament Light Levels With Long-term Brain Atrophy in Patients With a First Multiple Sclerosis Episode

IMPORTANCE: Data are needed on the potential long-term prognostic association of serum neurofilament light in multiple sclerosis (MS). OBJECTIVE: To evaluate serum neurofilament light as a biomarker associated with long-term disease outcomes in clinically isolated syndrome. DESIGN, SETTING, AND PART...

Descripción completa

Detalles Bibliográficos
Autores principales:	Plavina, Tatiana, Singh, Carol M., Sangurdekar, Dipen, de Moor, Carl, Engle, Bob, Gafson, Arie, Goyal, Jaya, Fisher, Elizabeth, Szak, Suzanne, Kinkel, Revere P., Sandrock, Alfred W., Su, Ray, Kieseier, Bernd C., Rudick, Richard A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645699/ https://www.ncbi.nlm.nih.gov/pubmed/33151313 http://dx.doi.org/10.1001/jamanetworkopen.2020.16278

Ejemplares similares

Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoring
por: Calabresi, Peter A, et al.
Publicado: (2020)

Neurofilament light levels are associated with long-term outcomes in multiple sclerosis
por: Kuhle, Jens, et al.
Publicado: (2019)

Measuring treatment response to advance precision medicine for multiple sclerosis
por: Calabresi, Peter A., et al.
Publicado: (2021)

Blood neurofilament light levels segregate treatment effects in multiple sclerosis
por: Delcoigne, Bénédicte, et al.
Publicado: (2020)

Serum Neurofilament Light and Multiple Sclerosis Progression Independent of Acute Inflammation
por: Gafson, Arie R., et al.
Publicado: (2022)

Development of a Highly Sensitive Neurofilament Light Chain Assay on an Automated Immunoassay Platform
por: Lee, Stephen, et al.
Publicado: (2022)

Neurofilament as a potential biomarker for spinal muscular atrophy
por: Darras, Basil T., et al.
Publicado: (2019)

Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trial
por: Cutter, Gary, et al.
Publicado: (2023)

A classification based framework for quantitative description of large-scale microarray data
por: Sangurdekar, Dipen P, et al.
Publicado: (2006)

The association of DNA damage response and nucleotide level modulation with the antibacterial mechanism of the anti-folate drug Trimethoprim
por: Sangurdekar, Dipen P, et al.
Publicado: (2011)

Neurofilament light protein in blood predicts regional atrophy in Huntington disease
por: Johnson, Eileanoir B., et al.
Publicado: (2018)

The altered expression of neurofilament in mouse models and patients with spinal muscular atrophy
por: Spicer, Charlotte, et al.
Publicado: (2021)

Neurofilament light level correlates with brain atrophy, and cognitive and motor performance
por: Kartau, Marge, et al.
Publicado: (2023)

Reconstruction of Escherichia coli transcriptional regulatory networks via regulon-based associations
por: Zare, Hossein, et al.
Publicado: (2009)

Neurofilament light levels predict clinical progression and death in multiple system atrophy
por: Chelban, Viorica, et al.
Publicado: (2022)

Myosin Va binding to neurofilaments is essential for correct myosin Va distribution and transport and neurofilament density
por: Rao, Mala V., et al.
Publicado: (2002)

Serum neurofilament light as a biomarker in progressive multiple sclerosis
por: Kapoor, Raju, et al.
Publicado: (2020)

Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients
por: Sejbaek, Tobias, et al.
Publicado: (2019)

Age-Related Atrophy of Motor Axons in Mice Deficient in the Mid-Sized Neurofilament Subunit
por: Elder, Gregory A., et al.
Publicado: (1999)

Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease
por: Dhiman, Kunal, et al.
Publicado: (2020)

Chitinase 3–like 1 and neurofilament light chain in CSF and CNS atrophy in MS
por: Schneider, Ruth, et al.
Publicado: (2020)

Serum neurofilament light chain in pediatric spinal muscular atrophy patients and healthy children
por: Nitz, Elisa, et al.
Publicado: (2021)

Serum Creatine, Not Neurofilament Light, Is Elevated in CHCHD10-Linked Spinal Muscular Atrophy
por: Järvilehto, Julius, et al.
Publicado: (2022)

Guided Imagery Improves Mood, Fatigue, and Quality of Life in Individuals With Multiple Sclerosis: An Exploratory Efficacy Trial of Healing Light Guided Imagery
por: Case, Laura K., et al.
Publicado: (2018)

Implications of circulating neurofilaments for spinal muscular atrophy treatment early in life: A case series
por: Alves, Christiano R.R., et al.
Publicado: (2021)

Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer’s disease
por: Kang, Min Su, et al.
Publicado: (2020)

Neurofilament light is a novel biomarker for mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes
por: Zheng, Yong-Sheng, et al.
Publicado: (2021)

Serum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS Trial
por: Bar-Or, Amit, et al.
Publicado: (2022)

Transient Growth Arrest in Escherichia coli Induced by Chromosome Condensation
por: Edwards, Andrea L., et al.
Publicado: (2013)

Nusinersen treatment and cerebrospinal fluid neurofilaments: An explorative study on Spinal Muscular Atrophy type 3 patients
por: Faravelli, Irene, et al.
Publicado: (2020)

Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis
por: Prosperini, Luca, et al.
Publicado: (2019)

Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: Results from MS PATHS
por: Hersh, Carrie M, et al.
Publicado: (2021)

Comparison of neurofilament light and heavy chain in spinal muscular atrophy and amyotrophic lateral sclerosis: A pilot study
por: Li, Jin‐Yue, et al.
Publicado: (2023)

Neurofilament Light Chain in Spinal Fluid and Plasma in Multiple System Atrophy – A Prospective, Longitudinal Biomarker Study
por: Singer, Wolfgang, et al.
Publicado: (2023)

Author Correction: Neurofilament light is a novel biomarker for mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes
por: Zheng, Yong‑Sheng, et al.
Publicado: (2021)

Feasibility of the Use of Combinatorial Chemokine Arrays to Study Blood and CSF in Multiple Sclerosis
por: Edwards, Keith R., et al.
Publicado: (2013)

Absence of the Mid-sized Neurofilament Subunit Decreases Axonal Calibers, Levels of Light Neurofilament (NF-L), and Neurofilament Content
por: Elder, Gregory A., et al.
Publicado: (1998)

Differential dynamics of neurofilament-H protein and neurofilament-L protein in neurons
Publicado: (1994)

Neurofilament deficiency in quail caused by nonsense mutation in neurofilament-L gene
Publicado: (1993)

Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis
por: van Lierop, Zoë YGJ, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vgvjpo07kdnhmmjn2gltk82r39